- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Cangene Corporation
Total 8490 results
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI); Celgene CorporationCompletedMultiple MyelomaUnited States
-
Thomas KippsCelgene CorporationTerminatedChronic Lymphocytic LeukemiaUnited States
-
Arbeitsgemeinschaft medikamentoese TumortherapieMerck Sharp & Dohme LLC; Celgene CorporationTerminatedPeripheral T-Cell Non-Hodgkin's LymphomaAustria
-
Weill Medical College of Cornell UniversityAstraZeneca; Celgene CorporationActive, not recruitingMantle Cell LymphomaUnited States
-
Fundación General de la Universidad de SalamancaCelgene CorporationCompletedMyelodysplastic SyndromeGermany, Spain, France
-
US Oncology ResearchUniversity of Southern California; Celgene CorporationCompleted
-
Weill Medical College of Cornell UniversityPfizer; Celgene CorporationTerminatedMultiple MyelomaUnited States
-
AHS Cancer Control AlbertaAlberta Cancer Foundation; Celgene CorporationCompleted
-
Indiana University School of MedicineCelgene CorporationTerminatedHepatocellular CarcinomaUnited States
-
Groupe Francophone des MyelodysplasiesRoche Pharma AG; Celgene CorporationCompleted
-
IRCCS Centro di Riferimento Oncologico della BasilicataCelgene CorporationCompleted
-
Massachusetts General HospitalDana-Farber Cancer Institute; Celgene CorporationCompletedMyelodysplasiaUnited States
-
CelgeneNYU Langone Health; Syneos Health; Celerion; ApoCell, Inc.CompletedMalignant MelanomaUnited States
-
Hellenic Cooperative Oncology GroupEli Lilly and Company; Celgene CorporationCompleted
-
National Institute of Allergy and Infectious Diseases...Celgene CorporationCompleted
-
Memorial Sloan Kettering Cancer CenterCelgene Corporation; Miami Cancer InstituteCompletedLung Cancer | Untreated Stage IV or Recurrent Squamous Cell Lung CancersUnited States
-
Ohio State University Comprehensive Cancer CenterGenentech, Inc.; Celgene CorporationCompleted
-
NYU Langone HealthNew York City Health and Hospitals CorporationCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteCelgene CorporationCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteCelgene CorporationCompleted
-
The Christie NHS Foundation TrustCelgene Corporation; Leukemia Research FundTerminatedChronic Lymphocytic LeukaemiaUnited Kingdom
-
SCRI Development Innovations, LLCEli Lilly and Company; Celgene CorporationCompletedBreast CancerUnited States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Celgene CorporationCompletedEsophageal CancerNetherlands
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Celgene CorporationCompletedEsophageal Cancer | ToxicityNetherlands
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); Celgene CorporationTerminatedChronic Lymphocytic Leukemia | B-cell Chronic Lymphocytic Leukemia | Stage 0 Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic LeukemiaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCelgene CorporationCompletedMantle Cell Lymphoma | Lymphocytic LeukemiaUnited States
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...Celgene CorporationNot yet recruitingRelapsed or Refractory Follicular Lymphoma
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...Celgene CorporationRecruitingMultiple SclerosisUnited States, Belgium, France, Germany, Spain, United Kingdom, Italy
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...Celgene CorporationWithdrawnLeukemia, Lymphocytic, Chronic, B-CellUnited States, Austria, Belgium, France, Germany, Italy, Netherlands, Norway, Spain, Sweden, United Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Celgene CorporationCompletedAzacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)Leukemia | Stem Cell TransplantationUnited States
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLC; Celgene CorporationCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteCelgene CorporationCompletedMyelodysplastic Syndrome | MDSUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCelgene CorporationCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Celgene CorporationCompletedProstate CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Celgene CorporationCompletedAllogeneic GM-CSF Vaccine and Lenalidomide in Treating Myeloma Patients With Near Complete RemissionMultiple MyelomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Celgene CorporationTerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
Leslie AndritsosCelgene CorporationCompletedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Chronic Lymphocytic LeukemiaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Celgene CorporationCompletedChronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult... and other conditionsUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Celgene CorporationCompletedSolid Tumors | Virally Mediated Cancers and LiposarcomaUnited States
-
NYU Langone HealthNew York City Health and Hospitals CorporationCompleted
-
University of CincinnatiMedical University of South Carolina; Celgene CorporationCompletedSarcoidosis | Cutaneous SarcoidosisUnited States
-
Wuerzburg University HospitalCelgene Corporation; Amgen; ClinAssess GmbH; medac GmbHCompleted
-
Peter MacCallum Cancer Centre, AustraliaCelgene Corporation; Janssen-Cilag Ltd.UnknownMultiple MyelomaAustralia
-
Alliance Foundation Trials, LLC.Takeda; Janssen Scientific Affairs, LLC; Celgene CorporationActive, not recruitingMyeloma, MultipleUnited States
-
Heinrich-Heine University, DuesseldorfCelgene Corporation; Koordinierungszentrum für Klinische Studien DüsseldorfActive, not recruitingMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Chronic Myelomonocytic Leukemia | IDH2 Gene Mutation | IDH2 R172 | IDH2 R140Germany
-
OHSU Knight Cancer InstituteOregon Health and Science University; Celgene CorporationCompletedPancreatic Adenocarcinoma | Resectable Pancreatic CarcinomaUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.; Celgene CorporationCompletedNon-small Cell Lung CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis; Celgene CorporationActive, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Ohio State University Comprehensive Cancer CenterMillennium Pharmaceuticals, Inc.; Celgene CorporationCompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Steven P. Treon, MD, PhDCelgene CorporationTerminatedWaldenstrom's MacroglobulinemiaUnited States